Dr Saadvik Raghuram Y - Best Medical and Hemato-Oncologist in Banjara Hills, Hyderabad

Brief Profile

Dr. Saadvik Raghuram Y is widely regarded as one of the best Medical and Hemato-Oncologist in Banjara Hills, Hyderabad, known for his expertise in the comprehensive management of solid tumors and blood cancers. He provides personalized, evidence-based cancer care using advanced treatment modalities including chemotherapy, targeted therapy, immunotherapy, precision oncology, and molecular-guided treatments.

He specializes in the treatment of breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, brain tumors, leukemia, lymphoma, and multiple myeloma, ensuring a multidisciplinary approach tailored to each patient.

With extensive experience in medical oncology and hemato-oncology, Dr. Saadvik focuses on delivering advanced cancer therapies, palliative oncology, and supportive care, aiming to improve survival outcomes while maintaining the best possible quality of life for patients.

Dr. Saadvik Raghuram Y has contributed to national and international research publications and has received multiple recognitions for his academic excellence and contributions to oncology. He is committed to bringing latest global cancer treatments and evidence-based protocols to his patients.

He completed his MBBS from JSS Medical College, MD in Radiation Oncology from Sri Aurobindo Medical College, and DM in Medical Oncology from Amrita Institute of Medical Sciences. He is an active member of prestigious international oncology societies including ESMO, ASCO, and ASH.

Field(s) of Expertise

• Chemotherapy & Targeted Therapy 
• Immunotherapy & Precision Oncology 
• Hemato-Oncology & Blood Disorders 
• Multidisciplinary Cancer Care (Breast, Stomach, Colorectal, Liver, Esophageal, Prostate, Kidney, Bladder, Oral, Brain tumours, and Lung cancers)
• Palliative & Supportive Oncology
   

Publications

• Thromboembolic events in advanced non-small cell lung cancer. Annals of oncology (2019)30 (suppl_2): ii38-1168.10.1093/annoc/mdz063.
• Rising thyroid cancer incidence in Kerala: Is it real or over diagnosis? J Clin Oncol 37(15_suppl):e17589.May 2019.
• The value of low, fixed, single dose rasburicase in the prevention and treatment of tumor lysis syndrome. J Clin Oncol 37, 2019(suppl;e 18558)
• The association of the uterine motion with bladder volume during radiotherapy in gynaecological malignancies. Journal of Cancer Metastasis and Treatment. 2016;2(4):139.
• Incidence of second primary malignant neoplasm in Malwa region of central India – Journal of Cancer Research and Therapeutics,14(5),999.
• Pemetrexed-Associated Hyperpigemented Skin Rash. American journal of therapeutics. U.S. National Library of Medicine; 2020.Available from: https://www.ncbi.nlm.nih.gov/pubmed/32039988.
• Orbital metastasis as the presenting feature of carcinoma breast. Indian Journal of cancer education and research. 4. 67-70. 10.21088/ijcer.2321.9815.4216.5.
• Efficacy and safety of trastuzumab emtansine biosimilar in the treatment of HER2-positive metastatic breast cancer: A real-world multicenter study.
• ESMO OPEN. http://dx.doi.org/10.1016/j.esmoop.2025.104955
• Molecular insights from comprehensive genomic profiling data in advanced metastatic colorectal cancer in South Asian population: A retrospective
• observational study. Cancer Research, Statistics and Treatment 7(2):p 193-205, Apr–Jun 2024. | DOI: 10.4103/crst.crst_30_24
• Recurrent extramedullary plasmacytomas without multiple myeloma: A case report with review of the literature. Cancer Treat Res Commun.
• Raghuram S, Faizal B, Sanjeevan KV, Eapen M, Nair IR, Philip A, Pavithran K. 2022;31:100550. doi: 10.1016/j.ctarc.2022.100550. Epub 2022 Mar 25. PMID: 35358819.
• Mutations in a High-Grade Micropapillary Urothelial Carcinoma of the Renal Pelvis: A Case ReportMutations in a High-Grade Micropapillary Urothelial Carcinoma of the Renal Pelvis: A Case Report. http://dx.doi.org/10.1159/000530710http://dx.doi.org/10.1159/000530710.
• Coexistence of hemophagocytic lymphohistiocytosis and Kikuchi disease –Are they continuum of single entity or two different entities?
• http://dx.doi.org/10.4103/jdap.jdap_28_24
• A Rare Case of Skull Base Phosphaturic Mesenchymal Tumor. http://dx.doi.org/10.37549/ARO-D-24-00004.
• Case Report of a Glioma Patient with Homozygous Missense Amino Acid Substitution in KDR Gene. http://dx.doi.org/10.1055/s-0043-1762919 , http://dx.doi.org/10.1055/s-0043-1762919

Education

• MBBS - JSS Medical College, Mysore
• MD (Radiation Oncology) - Sri Aurobindo Medical College, Indore
• DM (Medical Oncology) - Amrita Institute of Medical Sciences, Kochi
• MRCP, SCE, UK
• ECMO

Awards and Recognitions

• FIRST PRIZE IN QUIZ: Oncology 2018: International conference on multidisciplinary management of common cancers, October 2018
• FIRST PRIZE IN QUIZ: Amala Oncology Breast Cancer Conference, March 2020.
• SECOND PRIZE FOR BEST ORAL PAPER: Indian Association of supportive care in cancer (IASCC) under the aegis of Multinational association of supportive care in cancer (MASCC) September 2020. Prevalence of distress among cancer patients and factors associated with it: A prospective observational study.
• THIRD PRIZE FOR BEST POSTER PRESENTATION AROICON MP-CG chapter 2016. Primary squamous cell carcinoma of breast: A case report
• ESMO PRECEPTORSHIP COURSE on Prostate cancer advancements- TRAVEL GRANT by European society of medical oncology, SINGAPORE
• ESMO PRECEPTORSHIP COURSE on Bladder and Kidney cancer- TRAVEL GRANT by European Society of medical oncology, SINGAPORE

Languages Known

English, Hindi, Malayalam, Kannada and Telugu

Fellowship/Membership

• Member, European Society of Medical Oncology (ESMO) – ID No: 412228
• American Society of Clinical Oncology (ASCO)
• American Society of Hematology (ASH)
• Indian Society of Medical and Paediatric Oncology (ISMPO)- ID No: 1432 Member, Chapter

Past Positions

• Resident radiation oncology (SAIMS) 2014-2017
• Senior Resident, Medical Oncology, 2017-2020 (AIMS)
• Consultant Medical Oncology 2020-2024 (Medicover Hospitals, HITEC City)
• Head of Department Medical Oncology 2024-2026 (Arete Hospitals, Gachibowli)